These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1715 related items for PubMed ID: 1617306

  • 1. Lipids and cardiovascular disease: do the findings and therapy apply equally to men and women?
    LaRosa JC.
    Womens Health Issues; 1992; 2(2):102-11; discussion 111-3. PubMed ID: 1617306
    [Abstract] [Full Text] [Related]

  • 2. Oral contraceptive and postmenopausal estrogen effects on lipoprotein triglyceride and cholesterol in an adult female population: relationships to estrogen and progestin potency.
    Knopp RH, Walden CE, Wahl PW, Hoover JJ, Warnick GR, Albers JJ, Ogilvie JT, Hazzard WR.
    J Clin Endocrinol Metab; 1981 Dec; 53(6):1123-32. PubMed ID: 7298796
    [Abstract] [Full Text] [Related]

  • 3. The metabolic impact of oral contraceptives.
    Krauss RM, Burkman RT.
    Am J Obstet Gynecol; 1992 Oct; 167(4 Pt 2):1177-84. PubMed ID: 1415443
    [Abstract] [Full Text] [Related]

  • 4. Sex hormones and cardiovascular risk.
    La Vecchia C.
    Hum Reprod; 1992 Feb; 7(2):162-7. PubMed ID: 1577926
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Cholesterol, lipoproteins, and coronary heart disease in women.
    Bush TL, Fried LP, Barrett-Connor E.
    Clin Chem; 1988 Feb; 34(8B):B60-70. PubMed ID: 3042201
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Serum high density lipoprotein cholesterol levels in Chinese healthy subjects and patients with certain diseases.
    Cai HJ, Li ZX, Yang SM.
    Atherosclerosis; 1982 Jun; 43(2-3):197-207. PubMed ID: 7115460
    [Abstract] [Full Text] [Related]

  • 9. Oral contraceptives and coronary heart disease: modulation of glucose tolerance and plasma lipid risk factors by progestins.
    Crook D, Godsland IF, Wynn V.
    Am J Obstet Gynecol; 1988 Jun; 158(6 Pt 2):1612-20. PubMed ID: 3287933
    [Abstract] [Full Text] [Related]

  • 10. Women, lipoproteins and cardiovascular disease risk.
    LaRosa JC.
    Can J Cardiol; 1990 May; 6 Suppl B():23B-29B. PubMed ID: 2188715
    [Abstract] [Full Text] [Related]

  • 11. Distribution of lipoproteins triglyceride and lipoprotein cholesterol in an adult population by age, sex, and hormone use- The Pacific Northwest Bell Telephone Company health survey.
    Wahl PW, Warnick GR, Albers JJ, Hoover JJ, Walden CE, Bergelin RO, Ogilvie JT, Hazzard WR, Knopp RH.
    Atherosclerosis; 1981 Apr; 39(1):111-24. PubMed ID: 6941788
    [Abstract] [Full Text] [Related]

  • 12. Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol.
    Wahl P, Walden C, Knopp R, Hoover J, Wallace R, Heiss G, Rifkind B.
    N Engl J Med; 1983 Apr 14; 308(15):862-7. PubMed ID: 6572785
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Lipids, cardiovascular disease, and oral contraceptives: a practical perspective.
    Upton GV.
    Fertil Steril; 1990 Jan 14; 53(1):1-12. PubMed ID: 2403935
    [Abstract] [Full Text] [Related]

  • 15. [Can breast cancer be prevented?].
    Vatten LJ.
    Tidsskr Nor Laegeforen; 1991 May 30; 111(14):1745-8. PubMed ID: 2063386
    [Abstract] [Full Text] [Related]

  • 16. Progestins and oral contraceptive-induced lipoprotein changes: a prospective study.
    Lipson A, Stoy DB, LaRosa JC, Muesing RA, Cleary PA, Miller VT, Gilbert PR, Stadel B.
    Contraception; 1986 Aug 30; 34(2):121-34. PubMed ID: 3096633
    [Abstract] [Full Text] [Related]

  • 17. Associations of oral contraceptive use with serum lipids and lipoproteins in young women: the Bogalusa Heart Study.
    Greenlund KJ, Webber LS, Srinivasan S, Wattigney W, Johnson C, Berenson GS.
    Ann Epidemiol; 1997 Nov 30; 7(8):561-7. PubMed ID: 9408552
    [Abstract] [Full Text] [Related]

  • 18. Effect of two oral contraceptives containing ethinyl estradiol and gestodene or norgestimate on different lipid and lipoprotein parameters.
    Wiegratz I, Jung-Hoffmann C, Gross W, Kuhl H.
    Contraception; 1998 Aug 30; 58(2):83-91. PubMed ID: 9773262
    [Abstract] [Full Text] [Related]

  • 19. Oral contraceptive tablets containing 20 and 30 micrograms of ethinyl estradiol with 150 micrograms desogestrel. Their influence on lipids, lipoproteins, sex hormone binding globulin and testosterone.
    Akerlund M, Almström E, Högstedt S, Nabrink M.
    Acta Obstet Gynecol Scand; 1994 Feb 30; 73(2):136-43. PubMed ID: 8116352
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 86.